Michael Møller
Impact in
- Genetics top 0.5%
- Chronic Lymphocytic Leukemia Research
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Pathology and Forensic Medicine top 0.5%
- Lymphoma Diagnosis and Treatment
Papers in
-
- Lymphoma Diagnosis and Treatment 65
- Genetics 39
- Chronic Lymphocytic Leukemia Research 25
- Myeloproliferative Neoplasms: Diagnosis and Treatment 13
- Co-authors
- Thomas Kielsgaard Kristensen (24 shared papers)Hanne Vestergaard (19 shared papers)Niels T. Pedersen (13 shared papers)Bjarne Christensen (9 shared papers)Ole Nielsen (7 shared papers)Sigurd Broesby‐Olsen (17 shared papers)Carsten Bindslev‐Jensen (14 shared papers)Ken H. Young (9 shared papers)
- Journals
- Blood (17 papers)European Journal Of Haematology (12 papers)British Journal of Haematology (6 papers)Leukemia (5 papers)American Journal of Hematology (3 papers)
- Partner nations
- DenmarkUnited StatesSpain
In The Last Decade
Michael Møller
158 papers receiving 4.3k citations
Michael Møller's Hit Papers
Peers
Comparison fields: 5 of 139
- Genetics 959
- Pathology and Forensic Medicine 1.5k
- Immunology and Allergy 281
- Immunology 919
- Oncology 1.1k
Countries citing papers authored by Michael Møller
This map shows the geographic impact of Michael Møller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Møller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Møller more than expected).
Fields of papers citing papers by Michael Møller
This network shows the impact of papers produced by Michael Møller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Møller. The network helps show where Michael Møller may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael Møller, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 165 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Immunohistochemical Double-Hit Score Is a Strong Predictor of Outcome in Patients With Diffuse Large B-Cell Lymphoma Treated With Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Hit paper breakdown → | 2012 | 496 |
| 2 | 2011 | 287 | |
| 3 | 1999 | 215 | |
| 4 | 2003 | 202 | |
| 5 | 2011 | 147 | |
| 6 | 2014 | 137 | |
| 7 | 2007 | 122 | |
| 8 | 2012 | 120 | |
| 9 | 1994 | 100 | |
| 10 | 2014 | 87 | |
| 11 | 1999 | 86 | |
| 12 | 2017 | 75 | |
| 13 | 2013 | 75 | |
| 14 | 2000 | 75 | |
| 15 | 2011 | 70 | |
| 16 | 2012 | 69 | |
| 17 | Disrupted p53 function as predictor of treatment failure and poor prognosis in B- and T-cell non-Hodgkin's lymphoma. | 1999 | 66 |
| 18 | 2009 | 66 | |
| 19 | 2000 | 64 | |
| 20 | Systemic mastocytosis--a systematic review. | 2012 | 59 |
About Michael Møller
Michael Møller is a scholar working on Pathology and Forensic Medicine, Genetics, Oncology, Immunology and Molecular Biology, having authored 165 papers that have together received 4.4k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (65 papers), Chronic Lymphocytic Leukemia Research (25 papers), Viral-associated cancers and disorders (23 papers), Mast cells and histamine (16 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (13 papers), Eosinophilic Disorders and Syndromes (11 papers), CNS Lymphoma Diagnosis and Treatment (8 papers) and Cancer-related Molecular Pathways (8 papers). The work is most often cited by research in Genetics (959 citations), Pathology and Forensic Medicine (1.5k citations), Immunology and Allergy (281 citations), Immunology (919 citations) and Oncology (1.1k citations). Michael Møller has collaborated with scholars based in Denmark, United States and Spain. Frequent co-authors include Thomas Kielsgaard Kristensen, Hanne Vestergaard, Niels T. Pedersen, Bjarne Christensen, Ole Nielsen, Sigurd Broesby‐Olsen, Carsten Bindslev‐Jensen, Ken H. Young, Zijun Y. Xu‐Monette and Hans Carl Hasselbalch. Their work appears in journals such as Blood, European Journal Of Haematology, British Journal of Haematology, Leukemia and American Journal of Hematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.